At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where 'Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.

Exec Dir Early Pipeline Comercialization 

Bayer is seeking a strategic, commercially driven leader to join the organization as Executive Director, Oncology Pipeline Commercial Strategy Lead. This role will lead commercial strategy development across Bayer’s oncology pipeline, spanning early-, mid-, and late-stage assets. The successful candidate will help shape differentiated asset strategies, inform portfolio choices, and strengthen launch readiness to support Bayer’s long-term oncology growth ambitions. This leader will bring deep oncology expertise, strong executive presence, and the ability to influence effectively across a complex, matrixed environment.

YOUR TASKS AND RESPONSIBILITIES

The primary responsibilities of this role, Executive Director Early Pipeline Commercialization are to: 

• Lead the development of integrated commercial strategies for oncology pipeline assets across early, mid, and late stages of development. Lead commercial assessment of partnering opportunities;
• Provide strategic commercial input on disease area opportunity, competitive landscape, unmet need, treatment paradigm evolution, patient journey, and market access considerations;
• Partner closely with R&D, BD&L medical affairs, market access, finance, business development, and regional and local commercial teams to shape development and commercialization plans;
• Inform key governance decisions through robust commercial assessments, including indication prioritization, lifecycle strategy, portfolio trade-offs, and investment decisions;
• Define target product profiles, strategic positioning, segmentation approaches, and value proposition frameworks for pipeline assets;
• Guide insight generation, market research, forecasting assumptions, scenario planning, and opportunity sizing;
• Ensure commercial perspectives are embedded in milestone decisions from early development through pre-launch planning;
• Support development of launch strategies and launch readiness plans, including market shaping, stakeholder engagement, access strategy, and organizational preparedness;
• Drive portfolio prioritization discussions by evaluating commercial attractiveness, strategic fit, competitive intensity, and execution feasibility;
• Identify strategic risks and opportunities and recommend actions to optimize future asset value.

Leadership Expectations

• Serve as a senior strategic leader and trusted commercial thought partner within Bayer’s organization;
• Influence stakeholders across a global matrix through strong strategic reasoning, communication, and sound judgment;
• Lead with a patient-centered, science-informed, and performance-oriented mindset;
• Create alignment across diverse functions and regions while navigating ambiguity and competing priorities;
• Promote high-quality analysis, disciplined decision-making, and strong execution focus;
• Model VACC leadership principles (Visionary, Architect, Catalyst, Coach).

Therapeutic Area Expertise

The ideal candidate will bring strong oncology therapeutic area expertise, including a demonstrated understanding of:

• Oncology treatment paradigms and evolving standards of care;
• Biomarker-driven and precision medicine approaches;
• Solid tumors market dynamics;;
• Clinical development and commercialization considerations across the oncology lifecycle
• Stakeholder needs across providers, patients, payers, and health systems;;
• Competitive intelligence and market access dynamics relevant to oncology

Working relations: Global

• Global commercial, medical, clinical development, market access, and portfolio teams;
• Regional and local market leaders;
• Forecasting, analytics, finance, regulatory, insights, and operations functions;
• Senior governance and portfolio review bodies.

WHO YOU ARE

Bayer seeks an incumbent who possesses the following:

Required Qualifications:

• Bachelor’s degree required e.g. in business, life sciences, healthcare, pharmacy, public health, medicine, or a related field required;
• Significant experience in the biopharmaceutical, pharmaceutical, or biotechnology industry in commercial strategy, new product planning, pipeline strategy, portfolio strategy, marketing, consulting, or related functions;
• Meaningful experience in oncology;
• Proven success developing commercial strategies for pipeline and/or inline oncology assets;
• Strong understanding of drug development, commercialization planning, launch strategy, and market access;
• Experience working in complex, matrixed organizations with global and cross-regional stakeholders;
• Strong strategic, analytical, and problem-solving capabilities;
• Excellent communication skills, executive presence, and stakeholder management ability;
• Demonstrated team leadership and/or success leading through influence at senior levels;
• Build, coach, and develop high-performing talent;
• Set clear priorities and elevate strategic thinking across the team;
• Foster an inclusive environment that welcomes diverse perspectives and constructive challenge;
• Mentor team members and strengthen organizational capability in oncology pipeline commercial strategy;
• Lead effectively through influence across functions, markets, and seniority levels;
• Strategic and enterprise mindset;
• Strong business acumen and sound judgment;
• Learning agility and comfort operating in ambiguity;
• Highly collaborative and effective in matrixed environments;
• Data-driven and analytically rigorous;
• Decisive, proactive, and execution-oriented;
• Strong people leadership and talent development capability;
• Clear, persuasive communicator;
• High integrity, accountability, and professionalism;
• Commitment to patient impact and scientific innovation.

Preferred Qualifications:

• Advanced degree such as MBA, MPH, PharmD, PhD, MD, or other relevant graduate degree;
• Experience in oncology new product planning, global marketing, or portfolio management;
• Experience supporting or leading pre-launch and launch readiness for oncology products;
• Exposure to both US and global oncology markets;
• Experience in biomarker-driven, precision oncology, or specialty care markets;
• Combination of industry and top-tier consulting and/or strategic planning experience.

Employees can expect to be paid a salary between $220,240 to $330,360.  Additional compensation may include a bonus or commission (if relevant).  Additional benefits include health care, vision, dental, retirement, PTO, sick leave, etc..  This salary range is merely an estimate and may vary based on an applicant’s location, market data/ranges, an applicant’s skills and prior relevant experience, certain degrees and certifications, and other relevant factors.

This posting will be available for application until at least 7/27/2026.